MEDIFAST INC — Director's Dealing 2022

Nov 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-11-04

Reporting Person: BROWN JEFFREY J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-08	Common Stock	P	11.872	$106.93	Acquired	2365.912	Direct
2022-11-04	Common Stock	P	560.972	$105.06	Acquired	36498.822	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3940	Indirect

Footnotes

F1: The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.

F2: The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.

F3: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.

F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.